Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Shares of Cintas Corporation (NASDAQ:CTAS) rose sharply during Wednesday’s session after the company reported better-than-expected third-quarter financial results and raised FY24 guidance.

Cintas posted GAAP earnings of $3.84 per share, beating market estimates of $3.59 per share. The company’s quarterly sales came in at $2.406 billion, versus expectations of $2.386 billion, according to data from Benzinga Pro.

Cintas shares climbed 9.7% to $694.62 on Wednesday.

Here are some other big stocks recording gains in today’s session.

• PaySign, Inc. (NASDAQ:PAYS) shares jumped 28.2% to $4.3299 after the company announced better-than-expected fourth-quarter results.
• Noah Holdings Limited (NYSE:NOAH) climbed 17.5% to $11.89 after the company reported fourth quarter financial results.
• NuScale Power Corporation (NYSE:SMR) gained 17.5% to $4.89.
• The ONE Group Hospitality, Inc. (NASDAQ:STKS) shares climbed 17.2% to $4.70 after the company announced that it will acquire Safflower Holdings.
• Trump Media & Technology Group Corp. (NASDAQ:DJT) climbed 16.7% to $67.68 after jumping 16% on Tuesday.
• nCino, Inc. (NASDAQ:NCNO) rose 15.2% to $34.78 as the company reported better-than-expected fourth-quarter results and issued FY25 adjusted earnings guidance above estimates..
• Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) gained 11.6% to $2.22.
• Nuvation Bio Inc. (NYSE:NUVB) rose 11.3% to $3.2050 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $1.40 to $10.
• Annexon, Inc. (NASDAQ:ANNX) gained 10.6% to $7.61 following quarterly results.
• NovoCure Limited (NASDAQ:NVCR) gained 8.6% to $14.19 after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial progression for brain metastases from non-small cell lung cancer.
• Akebia Therapeutics, Inc. (NASDAQ:AKBA) gained 8% to $2.16.
• Semtech Corporation (NASDAQ:SMTC) shares gained 7.8% to $27.12.
• Marvell Technology, Inc. (NASDAQ:MRVL) rose 5.6% to $72.04.
• The E.W. Scripps Company (NASDAQ:SSP) gained 5.6% to $3.8650.
• Wayfair Inc. (NYSE:W) rose 5.4% to $68.27.
• Merck & Co., Inc. (NYSE:MRK) gained 4.4% to $131.09 after the company received FDA approval for Winrevair (sotatercept) for adults with pulmonary arterial hypertension.
• Kohl's Corporation (NYSE:KSS) rose 4.1% to $27.36.

Now Read This: Top 3 Consumer Stocks That May Rocket Higher This Quarter